Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection.

Citron, D M; Babakhani, F; Goldstein, E J C; Nagaro, K; Sambol, S; Sears, P; Shue, Y-K; Gerding, D N

Citron, D M; Babakhani, F; Goldstein, E J C; Nagaro, K; Sambol, S; Sears, P; Shue, Y-K; Gerding, D N.

Affiliation

Citron DM; RM Alden Research Lab, Culver City, CA, USA.

Anaerobe ; 15(6): 234-6, 2009 Dec.

Article in En | MEDLINE | ID: mdl-19755166

Subject(s)

Anti-Bacterial Agents; Clostridioides difficile/classification; Clostridioides difficile/drug effects; Enterocolitis, Pseudomembranous/epidemiology; Glycosides; Anti-Bacterial Agents/administration & dosage; Anti-Bacterial Agents/pharmacology; Anti-Bacterial Agents/therapeutic use; Bacterial Typing Techniques; Clostridioides difficile/genetics; Clostridioides difficile/isolation & purification; DNA Restriction Enzymes/metabolism; Dose-Response Relationship, Drug; Enterocolitis, Pseudomembranous/drug therapy; Enterocolitis, Pseudomembranous/microbiology; Feces/microbiology; Glycosides/administration & dosage; Glycosides/pharmacology; Glycosides/therapeutic use; Humans; Microbial Sensitivity Tests; Prohibitins; Ribotyping; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Enterocolitis, Pseudomembranous / Clostridioides difficile / Glycosides / Anti-Bacterial Agents Type of study: Clinical_trials / Risk_factors_studies Limits: Humans Language: En Journal: Anaerobe Year: 2009 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google